{"id":243027,"date":"2026-08-21T21:03:21","date_gmt":"2026-08-22T02:03:21","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/08\/interpath001-trial-personalized-mrna-cancer-vaccine-for-melanoma"},"modified":"2026-08-21T21:03:21","modified_gmt":"2026-08-22T02:03:21","slug":"interpath001-trial-personalized-mrna-cancer-vaccine-for-melanoma","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/08\/interpath001-trial-personalized-mrna-cancer-vaccine-for-melanoma","title":{"rendered":"INTerpath001 Trial: Personalized mRNA Cancer Vaccine for Melanoma"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/interpath001-trial-personalized-mrna-cancer-vaccine-for-melanoma.webp\"><\/a><\/p>\n<p>The positive Phase 3 result therefore provides clinical validation, at the level of RFS and DMFS, of a strategy combining individualized neoantigen-directed immunotherapy with established PD-1 blockade.<\/p>\n<p>It is important, however, not to extend the current findings beyond what the trial has demonstrated.<\/p>\n<p>INTerpath-001 establishes efficacy endpoints in resected high-risk cutaneous melanoma. It does not yet establish that the same approach will be effective across other tumor types, nor does the currently available topline information identify which molecular or immunological characteristics predict benefit from the individualized therapy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The positive Phase 3 result therefore provides clinical validation, at the level of RFS and DMFS, of a strategy combining individualized neoantigen-directed immunotherapy with established PD-1 blockade. It is important, however, not to extend the current findings beyond what the trial has demonstrated. INTerpath-001 establishes efficacy endpoints in resected high-risk cutaneous melanoma. It does not [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-243027","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/243027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=243027"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/243027\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=243027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=243027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=243027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}